212 related articles for article (PubMed ID: 36504796)
21. Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS.
Fu S; Cheng R; Deng Z; Liu T
J Pharm Anal; 2021 Dec; 11(6):709-716. PubMed ID: 35028175
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.
Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP
Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293
[TBL] [Abstract][Full Text] [Related]
23. XiaoEr LianHuaQinqGan alleviates viral pneumonia in mice infected by influenza A and respiratory syncytial viruses.
Li W; Li T; Zhao C; Song T; Mi Y; Chuangfeng Z; Hou Y; Jia Z
Pharm Biol; 2022 Dec; 60(1):2355-2366. PubMed ID: 36444944
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].
Li Q; Yin J; Ran QS; Yang Q; Liu L; Zhao Z; Li YJ; Chen Y; Sun LD; Wang YJ; Weng XG; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2317-2323. PubMed ID: 31359658
[TBL] [Abstract][Full Text] [Related]
25. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
Shi G; Kong J; Wang Y; Xuan Z; Xu F
J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
[TBL] [Abstract][Full Text] [Related]
26. New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment.
Tianyu Z; Xiaoli C; Yaru W; Min Z; Fengli Y; Kan H; Li C; Jing L
Aging (Albany NY); 2021 Nov; 13(21):23913-23935. PubMed ID: 34731090
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.
Ma C; Chen B; Li Y; Gu L; Dong J; Xu Z; Wei L; He Z; Nie X; Feng S; Cao B; Sun L; Yang L; Li X; Jiang R
Front Med (Lausanne); 2023; 10():1302219. PubMed ID: 38314028
[TBL] [Abstract][Full Text] [Related]
28. Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs.
Chen Y; Zhang C; Wang N; Feng Y
Chin J Nat Med; 2023 May; 21(5):383-400. PubMed ID: 37245876
[TBL] [Abstract][Full Text] [Related]
29. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
[TBL] [Abstract][Full Text] [Related]
30. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy and safety of Lianhua Qingwen capsule for influenza： a systematic review].
Niu QQ; Chen Y; Liu Y; Mao SZ; Wang H; Zheng WK; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1474-1481. PubMed ID: 29071849
[TBL] [Abstract][Full Text] [Related]
32. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
Ye Y; Wang H; Liu J; Zhao F; Xu P
Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of 999 XiaoErGanMao granules on the lungs and intestines of influenza A virus-infected mice.
Hao YZ; Cen LF; Wang T; Yi T; Shi XL; Duan HJ; Dai Z; Zhu HY; Tang JG
Pharm Biol; 2023 Dec; 61(1):630-638. PubMed ID: 37036063
[TBL] [Abstract][Full Text] [Related]
34. Ganghuo Kanggan Decoction in Influenza: Integrating Network Pharmacology and
Lai Y; Zhang Q; Long H; Han T; Li G; Zhan S; Li Y; Li Z; Jiang Y; Liu X
Front Pharmacol; 2020; 11():607027. PubMed ID: 33362562
[No Abstract] [Full Text] [Related]
35. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
[TBL] [Abstract][Full Text] [Related]
36. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of Lianhua Qingwen as an adjuvant treatment for influenza in Chinese patients: A meta-analysis.
Yuan C; Guan Y
Medicine (Baltimore); 2024 Jan; 103(3):e36986. PubMed ID: 38241551
[TBL] [Abstract][Full Text] [Related]
38. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.
Qiao Y; Xu X; Zhou F; Wang K; Li M; Liu C; Chen Z; Yin P; Shi Y; Wang Y; Liu Q
Phytomedicine; 2023 Apr; 112():154690. PubMed ID: 36780823
[TBL] [Abstract][Full Text] [Related]
39. Exploring the active ingredients and pharmacological mechanisms of the oral intake formula Huoxiang Suling Shuanghua Decoction on influenza virus type A based on network pharmacology and experimental exploration.
Tang R; Wang L; Zhang J; Li X; Tan L; He W; Han H; Liu Y; Wang K; Wang M
Front Microbiol; 2022; 13():1040056. PubMed ID: 36386710
[TBL] [Abstract][Full Text] [Related]
40. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Li WF; Hu CC; Ding YL; Yuan B
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
